Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MBX compared with TRVI: revenue, margins and what each company keeps, and the suppliers and customers both name
MBX
MBX Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
TRVI
Trevi Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MBX
MBX Biosciences, Inc.
vs
TRVI
Trevi Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
MBX
with
TRVI
Uncorrelated: r 0.13 · 500D.
Shared co-movers
1
with MBX
with TRVI
RNA
Atrium Therapeutics, Inc.
r 0.26
r 0.32
MBX, solid
TRVI, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
MBX
MBX Biosciences, Inc.
Change
55.82
▲
+2.35%
· post 55.27
Mkt cap
$2.7B
TRVI
Trevi Therapeutics, Inc.
Change
13.54
▼
−1.96%
· post 13.54
Closed
Oct 30 '26
Mkt cap
$1.9B
vs
Compare
Closed
Oct 30 '26
MBX
MBX Biosciences, Inc.
vs
TRVI
Trevi Therapeutics, Inc.
55.82
▲
+2.35%
post 55.27
Price
13.54
▼
−1.96%
post 13.54
$2.7B
Mkt cap
$1.9B
Change
Change
MBX
55.82
▲
+2.35%
vs
TRVI
13.54
▼
−1.96%
Closed
Oct 30 '26